FRM
CNMD icon

Fox Run Management’s CONMED CNMD Stock Holding History

Fox Run Management’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$662K Buy
19,776
+14,691
+289% +$598K 0.12% 323
2025
Q4 		$206K Buy
+5,085
New +$221K 0.03% 798
2024
Q2 		– Sell
-10,014
Closed -$802K – 818
2024
Q1 		$802K Buy
10,014
+7,448
+290% +$664K 0.17% 212
2023
Q4 		$281K Buy
+2,566
New +$265K 0.07% 515

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

Fox Run Management's CNMD Position: Q1 2026 in Review

Fox Run Management increased its CONMED (CNMD) stake by 289% in Q1 2026, buying an estimated $598K and bringing the position to 19,776 shares worth $662K. The position accounts for 0.12% of the portfolio, ranked #323.

Fox Run Management first reported a position in CNMD in Q4 2023 and has held it in 4 quarters since. The position peaked at $802K in Q1 2024. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • Fox Run Management held 19,776 shares of CONMED worth $662K as of Q1 2026.
  • Fox Run Management bought 14,691 CONMED shares in Q1 2026, an estimated $598K.
  • CONMED made up 0.12% of Fox Run Management's portfolio in Q1 2026, its #323 holding.
  • Fox Run Management first reported a position in CONMED in Q4 2023 and has held it in 4 quarters since.
  • Fox Run Management's CONMED position peaked at $802K in Q1 2024.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Fox Run Management's 13F filing for Q1 2026, filed 12 May 2026.